Target Name: BRWD3
NCBI ID: G254065
Review Report on BRWD3 Target / Biomarker Content of Review Report on BRWD3 Target / Biomarker
BRWD3
Other Name(s): Bromodomain and WD repeat-containing protein 3 | Bromo domain-containing protein disrupted in leukemia | BRWD3_HUMAN | MRX93 | XLID93 | bromodomain and WD repeat domain containing 3 | bromo domain-containing protein disrupted in leukemia | novel WD repeat domain protein | BRODL | Bromodomain and WD repeat domain containing 3

BRWD3: A Protein Involved in Many Cellular Processes

BRWD3, or Bromodomain and WD repeat-containing protein 3, is a protein that is expressed in almost all tissues of the human body. It is a 22kDa protein that is composed of two domains: a bromodomain domain and a WD repeat domain. The bromodomain domain is responsible for the protein's ability to interact with DNA, while the WD repeat domain is responsible for the protein's stability and localization to the nucleus.

BRWD3 is involved in many different cellular processes in the body, including DNA replication, transcription, and gene regulation. It is also involved in the development and progression of many diseases, including cancer.

One of the most promising aspects of BRWD3 is its potential as a drug target. Because BRWD3 is involved in so many different cellular processes, it is an attractive target for researchers to study and develop new treatments for a variety of diseases.

BRWD3 has been shown to be involved in the regulation of gene expression, specifically in the transcription of RNA. In addition, it has been shown to play a role in the regulation of DNA replication and repair.

BRWD3 is also involved in the regulation of cellular signaling, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases.

BRWD3 is also involved in the regulation of the cell cycle. It is a component of the nuclear envelope, which is responsible for regulating the movement of cellular proteins into and out of the nucleus.

In addition to its involvement in cellular signaling pathways, BRWD3 is also involved in the regulation of the immune system. It is a key regulator of the immune response, and is involved in the development and regulation of many different immune cell types.

BRWD3 is also involved in the regulation of the cell adhesion process. This process is responsible for the stickiness of cells to other cells and the formation of tissues.

BRWD3 is also involved in the regulation of the production of many different proteins, including enzymes involved in metabolism and signaling pathways.

In conclusion, BRWD3 is a protein that is involved in many different cellular processes in the body. Its potential as a drug target is due to its involvement in the regulation of gene expression, DNA replication, repair, cellular signaling pathways, the TGF-β pathway, the cell cycle, the immune system, and the cell adhesion process. Further research is needed to fully understand the role of BRWD3 in disease and to develop new treatments.

Protein Name: Bromodomain And WD Repeat Domain Containing 3

Functions: Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape

The "BRWD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BRWD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BSCL2 | BSDC1 | BSG | BSN | BSN-DT | BSND | BSPH1 | BSPRY | BST1 | BST2 | BSX | BTAF1 | BTBD1 | BTBD10 | BTBD16 | BTBD17 | BTBD18 | BTBD19 | BTBD2 | BTBD3 | BTBD6 | BTBD7 | BTBD8 | BTBD9 | BTC | BTD | BTF3 | BTF3L4 | BTF3P11 | BTF3P7 | BTF3P9 | BTG1 | BTG2 | BTG2-DT | BTG3 | BTG4 | BTK | BTLA | BTN1A1 | BTN2A1 | BTN2A2 | BTN2A3P | BTN3A1 | BTN3A2 | BTN3A3 | BTNL10P | BTNL2 | BTNL3 | BTNL8 | BTNL9 | BTRC | BUB1 | BUB1B | BUB1B-PAK6 | BUB3 | BUD13 | BUD23 | BUD31 | Butyrophilin | Butyrophilin subfamily 3 member A (BTN3A) | BVES | BVES-AS1 | BYSL | BZW1 | BZW1-AS1 | BZW1P2 | BZW2 | C-C chemokine receptor | C10orf105 | C10orf113 | C10orf120 | C10orf126 | C10orf143 | C10orf53 | C10orf55 | C10orf62 | C10orf67 | C10orf71 | C10orf71-AS1 | C10orf82 | C10orf88 | C10orf88B | C10orf90 | C10orf95 | C10orf95-AS1 | C11orf16 | C11orf21 | C11orf24 | C11orf40 | C11orf42 | C11orf52 | C11orf54 | C11orf58 | C11orf65 | C11orf68 | C11orf71 | C11orf80 | C11orf86 | C11orf87 | C11orf91